Comparison of Home and Office Blood Pressure Devices in the Clinical Setting.
Comparison of Home and Office Blood Pressure Devices in the Clinical Setting.
复制标题
家庭和办公室血压设备在临床环境中的比较。
DOI：
10.1093/ajh/hpad120
复制
发表时间：
2024
影响因子：
3.2
通讯作者：
Ishak,AnthonyM
中科院分区：
文献类型：
--
作者：
Juraschek,StephenP;Vyavahare,Medha;Cluett,JenniferL;Turkson-Ocran,Ruth-Alma;Mukamal,KennethJ;Ishak,AnthonyM
自我测量血压（SMBP）监测越来越多地用于远程高血压管理，但家庭血压（BP）设备的真实性能尚不清楚。我们研究了BP测量从患者的家庭设备使用美国医学会（AMA）SMBP设备准确性测试tool. METHODS病人在一个单一的内科诊所进行了多达五个座位，同臂BP读数使用家庭设备和自动BP设备（欧姆龙HEM-907 XL）。根据AMA的三步方案，我们使用患者的家用设备进行第一次、第二次和第四次测量，并使用办公室设备进行第三次和第五次（如果需要）测量。器械一致性失败定义为在两个确认步骤中的任何一个步骤中，家用和办公室器械之间的收缩压绝对差异>10 mm Hg。按品牌（Omron与非Omron）检查性能。此外，我们通过调整人口统计学特征的逻辑回归模型检查了与协议失败相关的患者因素。我们评估了2020年10月至2021年11月期间观察到的152名患者（平均年龄60±15岁，58%为女性，31%为黑人）。 22.4%（95% CI：16.4%，29.7%）的受试器械发生器械一致性失败，其中Omron器械为19.1%，非Omron器械为27.6%（P= 0.23）。 没有病人的特点与agreement failure. CONCLUSION超过五分之一的家庭设备不同意的基础上AMA SMBP设备的准确性协议。这些发现证实了基于办公室的设备比较的重要性，以确保家庭BP监测的准确性。
BACKGROUNDSelf-measured blood pressure (SMBP) monitoring is increasingly used for remote hypertension management, but the real-world performance of home blood pressure (BP) devices is unknown. We examined BP measurements from patients’ home devices using the American Medical Association’s (AMA) SMBP Device Accuracy Test tool.METHODSPatients at a single internal medicine clinic underwent up to five seated, same-arm BP readings using a home device and an automated BP device (Omron HEM-907XL). Following the AMA’s three-step protocol, we used the patient’s home device for the first, second, and fourth measurements and the office device for the third and fifth (if needed) measurements. Device agreement failure was defined as an absolute difference in systolic BP >10 mm Hg between the home and office devices in either of two confirmatory steps. Performance was examined by brand (Omron vs. non-Omron). Moreover, we examined patient factors associated with agreement failure via logistic regression models adjusted for demographic characteristics.RESULTSWe evaluated 152 patients (mean age 60 ± 15 years, 58% women, 31% Black) seen between October 2020 and November 2021. Device agreement failure occurred in 22.4% (95% CI: 16.4%, 29.7%) of devices tested, including 19.1% among Omron devices and 27.6% among non-Omron devices (P= 0.23). No patient characteristics were associated with agreement failure.CONCLUSIONSOver one-fifth of home devices did not agree based on the AMA SMBP device accuracy protocol. These findings confirm the importance of office-based device comparisons to ensure the accuracy of home BP monitoring.